Sansum Diabetes Research Institute

CLINICAL TRIALS

CURRENT ADULT STUDIES

Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients With Type 1 Diabetes

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

A Randomized Crossover Comparison of Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments in the Outpatient Setting for Patients with Type 1 Diabetes

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

Comparison of Insulin Degludec with Insulin Glargine U100 for adults with type 1 diabetes traveling across multiple time zones. A pilot study.

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

FreeStyle Libre Flash Glucose Monitoring System Post Approval Study

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Abbott Sensor Based Glucose Monitoring System Characterization Study using Capillary Glucose Reference.

Subjects must be: At least 18 years of age; require insulin therapy through an insulin pump and/or multiple daily injections (at least 3 injections daily), and be able to commit to 21 days participation.

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

YSI Feasibility Study of the Dexcom® Continuous Glucose Monitoring (CGM) System in Adults and Pediatrics with Diabetes Mellitus.

Must be: Ages 6 years or older, Diagnosed with Type 1 or Type 2 Diabetes Mellitus

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

CURRENT PEDIATRIC STUDIES

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

Freestyle Libre Flash Glucose Monitoring System Pediatric Accuracy Study

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Freestyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations.

Must be: 6-17 years of age and weigh at least 57.2 pounds.

More Information

Please contact Christian Farfan for more information, cfarfan@sansum.org or call 805-682-7640

CURRENT PREGNANCY STUDIES

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy (LOIS-P)

Evaluating the safety and accuracy of CGM in pregnancy. These research projects include an in-clinic portion and will have standard subject reimbursement. Principal Investigators: Kristin Castorino, DO and Jordan Pinsker, MD

More Information

Please contact Molly Piper for more information, mpiper@sansum.org or call 805-682-7640 ext. 214

CGM Accuracy in Pregnancy Research

Who: Pregnant women with any type of diabetes

When: Open Enrollment

Duration: Approximately 2 weeks

Please contact Kristen Nelson for more information, knelson@sansum.org or call 805-682-7640 ext. 252

GDM Prevention Study

We are a clinical site for CalPoly Stride Program’s GDM Prevention study. The gestational diabetes prevention program is studying whether weight loss before your next pregnancy can help prevent gestational diabetes from happening again. Principal Investigator: Suzanne Phelan, PhD

Who: Postpartum women with history of GDM who might have another baby

When: Open Enrollment

Duration: Approx 12 week intervention with follow-up if you become pregnant

More Information

Please contact Kristen Nelson for more information, knelson@sansum.org or call 805-682-7640 ext. 252

Sansum Diabetes Research Institute

CLINICAL TRIALS

CURRENT ADULT STUDIES

Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients With Type 1 Diabetes

A Randomized Crossover Comparison of Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments in the Outpatient Setting for Patients with Type 1 Diabetes

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

Comparison of Insulin Degludec with Insulin Glargine U100 for adults with type 1 diabetes traveling across multiple time zones. A pilot study.

Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)

FreeStyle Libre Flash Glucose Monitoring System Post Approval Study

Abbott Sensor Based Glucose Monitoring System Characterization Study using Capillary Glucose Reference.

YSI Feasibility Study of the Dexcom® Continuous Glucose Monitoring (CGM) System in Adults and Pediatrics with Diabetes Mellitus.

CURRENT PEDIATRIC STUDIES

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension

Freestyle Libre Flash Glucose Monitoring System Pediatric Accuracy Study

Freestyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients

FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations

Dexcom Continuous Monitoring and Control of Hypoglycemia (COACH)

Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations.

CURRENT PREGNANCY STUDIES

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy (LOIS-P)

CGM Accuracy in Pregnancy Research

GDM Prevention Study

FIND US

CALL